he emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought to light issues regarding regulations and their intricacies and boosted news trends in immuno-oncology, immuno- therapies, data interpretation and unconventional design of clinical trials.
MarketsandMarkets is pleased to announce the ‘Next Generation Companion Diagnostics Conference’ on 13th – 14th July, 2017 in Philadelphia, USA which will congregate experts from the field of personalized medicine and precision medicine from pharmaceutical and academic institutes and understand the emerging trends and challenges from their perspective. For more details, please contact Ajay at email@example.com.
- Multiplex Companion Diagnostics
- Commercialization of CDx
- Design of clinical trials in CDx
- Relevant Biomarkers in CDx
- CDx Regulatory guidelines